U.S. RESEARCH ROUNDUP-Altair Engineering, Applied Therapeutics, Microsoft

Eastman Chemical Co

26/03/2024 07:02

March 26 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Altair Engineering, Applied Therapeutics and
Microsoft on Tuesday.
    
  HIGHLIGHTS        
                 * Altair Engineering Inc  ALTR.O : JP Morgan raises target price to $95 from $86
 
                 * Applied Therapeutics Inc  APLT.O : RBC initiates with outperform rating; PT $12
 
                 * Microsoft  MSFT.O : Wedbush raises target price to $500 from $475
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.  
    
                 * Altair Engineering Inc  ALTR.O : JP Morgan raises target price to $95 from $86
 
                 * Applied Therapeutics Inc  APLT.O : RBC initiates with outperform rating; PT $12
 
                 * Astria Therapeutics Inc  ATXS.O : Jefferies raises target price to $27 from $22
 
                 * Axsome Therapeutics Inc  AXSM.O : RBC raises target price to $128 from $123
 
                 * Caseys General Stores Inc  CASY.O : JP Morgan raises target price to $299 from $271
 
                 * Eastman Chemical Co  EMN.N : Jefferies raises target price to $102 from $91
 
                 * Leggett & Platt Inc  LEG.N : Truist Securities cuts target price to $16 from $18
 
                 * Luminar  LAZR.O : JP Morgan cuts target price to $8 from $20
 
                 * Maplebear Inc  CART.O : Macquarie initiates coverage with outperform rating; PT $42
 
                 * Microsoft  MSFT.O : Wedbush raises target price to $500 from $475
 
                 * Nkarta Inc  NKTX.O : Canaccord Genuity raises target price to $16 from $15
 
                 * Open Lending Corp  LPRO.O : Canaccord Genuity cuts target price to $7 from $7.5
 
                 * Provident Financial Services Inc  PFS.N : RBC cuts target price to $19 from $21
 
                 * Sage Therapeutics Inc  SAGE.O : JP Morgan raises target price to $29 from $24
 
                 * Stoke Therapeutics Inc  STOK.O : Canaccord Genuity raises target price to $21 from $18
 
                 * Winnebago Industries Inc  WGO.N : D.A. Davidson raises target price to $66 from $64
 
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))